Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (VRNA, Financial), executed a significant transaction on October 22, 2024, where the insider sold 525,768 shares of the company. The sale was documented in a recent SEC Filing. Following this transaction, the insider now owns 13,813,920 shares of Verona Pharma PLC.
Verona Pharma PLC is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for respiratory diseases. Their focus includes treatments for conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
Over the past year, the insider has sold a total of 1,525,768 shares and has not made any purchases. This recent sale is part of a broader trend observed within the company, where there have been 9 insider sells and 3 insider buys over the past year.
Shares of Verona Pharma PLC were trading at $4.38 on the day of the transaction. The company's market cap is currently $2.83 billion.
For more detailed valuation metrics, such as the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, investors and analysts can visit the respective links.
This insider sale could be of interest to current and potential investors trying to understand the recent activities and financial decisions within Verona Pharma PLC.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
